Searched for
SAINUS PHARMACEUTICAL PRIVATE LIMITED
Udan vs Udaan: Delhi court restrains pharmaceutical firm from using 'Udaan' markA Delhi court has permanently stopped Sainus Pharmaceutical Private Limited from using the 'Udaan' trademark. This ruling came after RSPL H...- $400bn to $2tn: India’s alternative asset boom set to grow 5x by 2034, report showsIndia's alternative investment market could exceed two trillion dollars by 2034. High-net-worth individuals and family offices are driving ...
- Power sector stocks: Rising demand, uneven risk; best owned as a basket. 10 power stocks with upside potential of up to 28%For years, owning power meant betting on a slow, steady rise in demand as the economy grew. That story has suddenly changed. The machines b...
- Symbiotec Pharmalab gets Rs 526 crore anchor backing ahead of IPO; Citi Group, Singularity among investorsSymbiotec Pharmalab has raised Rs 526.20 crore from anchor investors ahead of its Rs 1,757 crore IPO opening August 24. The pharmaceutical ...
- One of a Kind Awards: Honouring the resourcefulness of bootstrapped championsAt the One of a Kind Awards - for early stage startups, presented by The Economic Times and Cashfree Payments, the Bootstrapped Champion Aw...
- ICICI Bank doubles borrowing from overseas markets to $5 billionICICI Bank has taken a significant step by doubling its overseas borrowing limit to five billion dollars. This strategic decision enhances ...
- Kronox Lab Sciences shares rally 32% in 2 days as Indo Borax, Zenrock Chemicals eye stake acquisitionShares of Kronox Lab Sciences surged after Indo Borax and Zenrock Chemicals announced plans to acquire a 64.26% stake in the company and la...
- Strikes in the Gulf changing rules behind India’s big-money betsIndia Private Equity Investment 2026: Geopolitical risks now shape private equity deal considerations in India. Investors increasingly focu...
- Glenmark Pharmaceuticals among 5 stocks showing bullish RSI upswingOn August 20, five Nifty500 stocks that gained over 4% were identified using the RSI Trending Up scan, based on data from StockEdge.com. An...
- Local funds' share rises in private credit market: EY reportPrivate credit investments were broadly similar to the second half of 2025 levels of $3.4 billion, with refinancing, holding-company fundin...
- Credent Connect shares make strong market debut, list at 90% premium over IPO price on NSE SME platformCredent Connect N Care shares made a blockbuster debut on the NSE SME platform, listing at a 90% premium over the IPO price. The Rs 93.90-c...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsHere’s one thing to watch for in the next few weeks: How does the street treat disappointments in the mid-cap segment? If the reaction is l...
- Pharma giant Cipla completes merger with wholly-owned subsidiary Inzpera Health SciencesPharmaceuticals giant Cipla announced its merger with Inzpera Healthsciences Limited on Wednesday. This consolidation aims for more efficie...
- Manipal Health Enterprises to acquire Kinder Women's Hospital in BengaluruManipal Health Enterprises will acquire Kinder Women's Hospital in Bengaluru for Rs 130 crore. This business transfer agreement involves ac...
- India's pharma sector must shift from cost competitiveness to innovation, global quality: ExpertsFor the growth of India's pharmaceutical sector, prioritizing innovation and advanced manufacturing is essential. Experts indicate that inc...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- Aurobindo Pharma’s Raleigh plant gets 'Voluntary Action Indicated' classification from US FDAAurobindo Pharma's US facility received a Voluntary Action Indicated classification. The US FDA closed its inspection of the Raleigh manufa...
- Need one or two Indian pharma firms to be among global top 5: PM ModiPrime Minister Modi urged Indian pharmaceutical companies to reach global top five. The Indian pharma industry ranks third globally by volu...
- MFs cut PSU bank exposure, raise bets on IT, auto & pharma in JulyIn July, fund managers recalibrated their blue-chip stock portfolios, focusing on select sectors like IT, automotive, and pharmaceuticals f...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
Load More
